GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Net Income (Discontinued Operations)

OncoTherapy Science (TSE:4564) Net Income (Discontinued Operations) : 円0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. OncoTherapy Science's Net Income (Discontinued Operations) for the three months ended in Sep. 2024 was 円0.0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.0 Mil.

OncoTherapy Science Net Income (Discontinued Operations) Historical Data

The historical data trend for OncoTherapy Science's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Net Income (Discontinued Operations) Chart

OncoTherapy Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoTherapy Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
TSE:4891 TSE:3750 TSE:2183 TSE:4893 TSE:4884 TSE:4584 TSE:4572 TSE:4598 TSE:2370 TSE:4570 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
30O:Germany
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
Website
http://www.oncotherapy.co.jp
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines